CDC launches coronavirus surveillance, testing at 5 U.S. labs

By staff writers

February 14, 2020 -- The U.S. Centers for Disease Control and Prevention (CDC) is utilizing state and local public health labs in five U.S. cities for community-based surveillance of the novel coronavirus, known as SARS-CoV-2.

Surveillance for the coronavirus will be conducted through the CDC's established network for monitoring influenza and will involve testing people with flu-like symptoms for SARS-CoV-2, the coronavirus that originated in Wuhan, China. The virus was previously known as 2019-nCoV.

Transmission electron microscopic image of an isolate from the first U.S. case of COVID-19
Transmission electron microscopic image of an isolate from the first U.S. case of COVID-19. The spherical extracellular viral particles contain cross-sections through the viral genome, seen as black dots. Image courtesy of the CDC.

The labs are located in the following cities:

  • Chicago
  • New York City
  • Los Angeles
  • San Francisco
  • Seattle

"This is just a starting point, and we plan to expand to more sites in the coming weeks until we have national surveillance," explained Dr. Nancy Messonnier, director of the CDC's National Center for Immunization and Respiratory Diseases, during a press briefing on February 14.

The plan is to leverage the existing influenza network to help detect if and when the novel coronavirus spreads to the community, she said. The surveillance network provides an early warning system to trigger a change in response.

The CDC has already distributed test kits to labs across the country, but problems were reported early on. Some labs stated that they obtained inconclusive results while validating the test at their facilities. During the February 14 briefing, Messonnier said that officials were still in the process of reformulating reagents for the test kits to resolve the problem and were moving rapidly while "holding ourselves to the highest standard."

Across the globe, there are 49,053 laboratory-confirmed cases, most in China, according to the World Health Organization's (WHO) February 14 situation report. Furthermore, the WHO reported that healthcare workers in China account for 1,716 confirmed cases, including six deaths, of COVID-19, the respiratory disease caused by the virus.

Messonnier said the new report about healthcare workers in China is very concerning. She stressed the importance of infection control in medical facilities and said that protecting healthcare workers on the front line is a high priority.

Coronavirus test gets CMS billing code
The U.S. Centers for Medicare and Medicaid Services (CMS) has developed a billing code in the Healthcare Common Procedure Coding System to be used by...
Coronavirus toll surges after sanction of CT diagnosis
The number of new confirmed cases of coronavirus disease (COVID-19) in China hit roughly 15,000 within the past 24 hours alone, a major increase, according...
CT imaging supplements lab tests for diagnosing coronavirus disease
Computed tomography (CT) was able to detect COVID-19, the disease caused by the 2019 novel coronavirus, in individuals with high clinical suspicion of...
WHO officially names coronavirus disease COVID-19
The World Health Organization (WHO) on February 11 announced an official designation for the disease caused by the novel coronavirus (2019-nCoV), naming...
CDC wrestles with coronavirus test problems in states
The U.S. Centers for Disease Control and Prevention (CDC) reported that there have been problems with some of the 2019-nCoV test kits sent out to labs...

Copyright © 2020

Last Updated eh 2/14/2020 5:47:51 PM

Register below for our weekly Letter from the Editor to receive the latest Clinical Lab news and insights.